Diabetic cardiomyopathy, causes and effects

[1]  E. Abel,et al.  Lipotoxicity in the heart. , 2010, Biochimica et biophysica acta.

[2]  P. Neufer,et al.  Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. , 2009, Journal of the American College of Cardiology.

[3]  Jeroen J. Bax,et al.  Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[4]  Godfrey L. Smith,et al.  Interval Training Normalizes Cardiomyocyte Function, Diastolic Ca2+ Control, and SR Ca2+ Release Synchronicity in a Mouse Model of Diabetic Cardiomyopathy , 2009, Circulation research.

[5]  E. Abel,et al.  Rodent models of diabetic cardiomyopathy , 2009, Disease Models & Mechanisms.

[6]  S. Bornstein,et al.  Adipocyte Fatty Acid–Binding Protein Suppresses Cardiomyocyte Contraction: A New Link Between Obesity and Heart Disease , 2009, Circulation research.

[7]  Ying Li,et al.  Rac1 Is Required for Cardiomyocyte Apoptosis During Hyperglycemia , 2009, Diabetes.

[8]  M. Karck,et al.  Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. , 2009, American journal of physiology. Heart and circulatory physiology.

[9]  F. Recchia,et al.  Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. , 2009, American journal of physiology. Heart and circulatory physiology.

[10]  A. Shiwalkar,et al.  TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes , 2009, Journal of cardiovascular pharmacology.

[11]  B. Ganesan,et al.  Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice , 2009, Diabetes.

[12]  R. Cooksey,et al.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. , 2009, Cardiovascular research.

[13]  Jeroen J. Bax,et al.  Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus , 2009, Circulation.

[14]  D. Ory,et al.  The Non-coding RNA gadd7 Is a Regulator of Lipid-induced Oxidative and Endoplasmic Reticulum Stress* , 2009, Journal of Biological Chemistry.

[15]  S. Boudina,et al.  Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart , 2009, Circulation.

[16]  D. Bluemke,et al.  Location of Arterial Stiffening Differs in Those With Impaired Fasting Glucose Versus Diabetes , 2009, Diabetes.

[17]  Jeroen J. Bax,et al.  Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[18]  Sheldon E. Litwin,et al.  Type 1 Diabetic Akita Mouse Hearts Are Insulin Sensitive but Manifest Structurally Abnormal Mitochondria That Remain Coupled Despite Increased Uncoupling Protein 3 , 2008, Diabetes.

[19]  G. Norton,et al.  Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. , 2008, American journal of hypertension.

[20]  D. Celermajer,et al.  Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[21]  S. Bansilal,et al.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. , 2008, The American journal of medicine.

[22]  R. Hajjar,et al.  Role of resistin in cardiac contractility and hypertrophy. , 2008, Journal of molecular and cellular cardiology.

[23]  R. Sacco,et al.  Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. , 2008, The American journal of cardiology.

[24]  S. Twigg,et al.  Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers , 2008, Vascular health and risk management.

[25]  R. Kronmal,et al.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.

[26]  G. Sweeney,et al.  Cardiac remodeling in obesity. , 2008, Physiological reviews.

[27]  E. Tadamura,et al.  Relation among Left Ventricular Mass, Insulin Resistance, and Hemodynamic Parameters in Type 2 Diabetes , 2008, Hypertension Research.

[28]  V. Palmieri,et al.  Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. , 2008, Diabetes research and clinical practice.

[29]  E. Abel,et al.  Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. , 2008, Clinical science.

[30]  J. Balligand,et al.  Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. , 2008, Cardiovascular research.

[31]  J. McGill,et al.  Fatty Acids and Insulin Modulate Myocardial Substrate Metabolism in Humans With Type 1 Diabetes , 2008, Diabetes.

[32]  D. Katritsis,et al.  Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[33]  K. Seung,et al.  Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus. , 2007, International journal of cardiology.

[34]  Xiaoming Sheng,et al.  Mitochondrial Energetics in the Heart in Obesity-Related Diabetes , 2007, Diabetes.

[35]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[36]  M. Galiñanes,et al.  Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: role of caspases and poly-adenosine diphosphate-ribose polymerase. , 2007, The Journal of thoracic and cardiovascular surgery.

[37]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[38]  W. Hsueh,et al.  Recipes for creating animal models of diabetic cardiovascular disease. , 2007, Circulation research.

[39]  K. Sunagawa,et al.  Angiotensin II Type 1 Receptor Blocker Attenuates Myocardial Remodeling and Preserves Diastolic Function in Diabetic Heart , 2007, Hypertension Research.

[40]  Ahmad Y. Sheikh,et al.  Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. , 2007, American journal of physiology. Heart and circulatory physiology.

[41]  J. Oh,et al.  Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography , 2006, Heart.

[42]  P. Herijgers,et al.  Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions , 2006, European journal of heart failure.

[43]  Xianlin Han,et al.  Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death Published, JLR Papers in Press, September 7, 2006. , 2006, Journal of Lipid Research.

[44]  M. Catalano,et al.  Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. , 2006, Endocrinology.

[45]  S. Proctor,et al.  Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[46]  Ling-Hao Li,et al.  Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. , 2006, Metabolism: clinical and experimental.

[47]  E. Abel,et al.  Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. , 2006, Physiology.

[48]  N. Standen,et al.  Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. , 2006, Cardiovascular research.

[49]  D. Severson,et al.  Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. , 2006, Diabetes.

[50]  A. Phan,et al.  Cardiac Myocyte Apoptosis Is Associated With Increased DNA Damage and Decreased Survival in Murine Models of Obesity , 2005, Circulation research.

[51]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[52]  E. Abel,et al.  Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. , 2005, Journal of molecular and cellular cardiology.

[53]  E. Abel,et al.  Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity , 2005, Circulation.

[54]  E. Ingelsson,et al.  Insulin resistance and risk of congestive heart failure. , 2005, JAMA.

[55]  T. Marwick,et al.  Screening for heart disease in diabetic subjects. , 2005, American heart journal.

[56]  R. Malik,et al.  Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. , 2004, Clinical science.

[57]  G. Noon,et al.  Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  Alex F. Chen,et al.  Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes , 2004, Circulation.

[59]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[60]  C. Dence,et al.  Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women , 2004, Circulation.

[61]  M. Ares,et al.  Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients. , 2004, International journal of cardiology.

[62]  A. J. Lambert,et al.  A signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling , 2003, The EMBO journal.

[63]  Markku Peltonen,et al.  Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure. , 2003, European heart journal.

[64]  E. Bollano,et al.  Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. , 2003, Endocrinology.

[65]  Jeroen J. Bax,et al.  Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. , 2003, Journal of the American College of Cardiology.

[66]  Kieran Clarke,et al.  Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes , 2003, Circulation.

[67]  S. Homma,et al.  Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. , 2003, The Journal of clinical investigation.

[68]  D. Severson,et al.  Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. , 2003, Diabetes.

[69]  D. Severson,et al.  Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[70]  D. Severson,et al.  Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator , 2002 .

[71]  H. Wakasaki,et al.  Expression of Connective Tissue Growth Factor Is Increased in Injured Myocardium Associated With Protein Kinase C β2 Activation and Diabetes , 2002 .

[72]  O. Frazier,et al.  Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C-Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure , 2002, Circulation.

[73]  J. Hare,et al.  Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice , 2002, Circulation.

[74]  C. Kahn,et al.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. , 2002, The Journal of clinical investigation.

[75]  Chu-Pak Lau,et al.  Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure , 2002, Circulation.

[76]  W. Dowhan,et al.  Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. , 2001, The Journal of biological chemistry.

[77]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[78]  Daniel S. Ory,et al.  Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway* , 2001, The Journal of Biological Chemistry.

[79]  P. Herrero,et al.  A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.

[80]  A. Maseri,et al.  Myocardial Cell Death in Human Diabetes , 2000, Circulation research.

[81]  B. Howard,et al.  Impact of diabetes on cardiac structure and function: the strong heart study. , 2000, Circulation.

[82]  K. Ohmori,et al.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. , 2000, Circulation.

[83]  Yangyu,et al.  Alteration in Left Ventricular Diastolic Filling and Accumulation of Myocardial Collagen at Insulin-Resistant Prediabetic Stage of a Type II Diabetic Rat Model , 2000 .

[84]  N. Dhalla,et al.  Subcellular remodeling and heart dysfunction in chronic diabetes. , 1998, Cardiovascular research.

[85]  S. Guruswamy,et al.  Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. , 1998, The Journal of biological chemistry.

[86]  S Dalla Volta,et al.  Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. , 1998, Journal of the American College of Cardiology.

[87]  M. Shimizu,et al.  Collagen remodelling in myocardia of patients with diabetes. , 1993, Journal of clinical pathology.

[88]  D. Levy,et al.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). , 1991, The American journal of cardiology.

[89]  S. Ahmed,et al.  Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.

[90]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[91]  S. Cook,et al.  Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. , 2010, European heart journal.

[92]  W. Sivitz,et al.  Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. , 2009, Endocrinology.

[93]  C. Vrints,et al.  Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. , 2006, The American journal of cardiology.

[94]  B. Culver,et al.  Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. , 2006, The Journal of endocrinology.

[95]  G. King,et al.  Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. , 2002, Diabetes.

[96]  M. Schocke,et al.  Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. , 2002, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[97]  H. Suga,et al.  Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. , 2002, American journal of physiology. Heart and circulatory physiology.